Healing Valuation

Is HLCO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HLCO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate HLCO's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate HLCO's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HLCO?

Key metric: As HLCO is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for HLCO. This is calculated by dividing HLCO's market cap by their current revenue.
What is HLCO's PS Ratio?
PS Ratio	0.001x
Sales	US$11.99m
Market Cap	US$12.02k

HLCO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.3x
Enterprise Value/EBITDA	-0.2x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does HLCO's PS Ratio compare to its peers?

The above table shows the PS ratio for HLCO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	6.1x
SMFL Smart for Life	0.01x	n/a	US$92.2k
MNKA Manuka	0.4x	n/a	US$235.3k
BDPT BioAdaptives	6.9x	n/a	US$246.3k
BFYW Better For You Wellness	17.2x	n/a	US$287.1k
HLCO Healing	0.001x	n/a	US$12.0k

Price-To-Sales vs Peers: HLCO is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (6.1x).

Price to Sales Ratio vs Industry

How does HLCO's PS Ratio compare vs other companies in the US Personal Products Industry?

28 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	1.0x	4.7%
HLCO Healing	0.001x	n/a	US$12.02k
HLF Herbalife	0.2x	1.8%	US$799.28m
NUS Nu Skin Enterprises	0.2x	-0.06%	US$376.81m

28 Companies		Estimated Growth	Market Cap
Industry Avg.	1.0x	25.4%
HLCO Healing	0.001x	n/a	US$12.02k

No more companies

Price-To-Sales vs Industry: HLCO is good value based on its Price-To-Sales Ratio (0x) compared to the US Personal Products industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is HLCO's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HLCO PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.001x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate HLCO's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Reynolds Consumer Products

US$5.7b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

REYN

US$27.47

-0.3%

3.8%

USANA Health Sciences

US$768.9m

Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe.

USNA

US$39.38

-4.6%

-14.8%

Kimberly-Clark de México S. A. B. de C. V

Mex$86.8b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.Y

Mex$7.05

-0.3%

-30.2%